Survival In Advanced Diffuse Large B-Cell Lymphoma In Pre- and Post-Rituximab Eras In The United States: A Population Based Study

被引：0
|
作者：
Bista, Amir
Shafii, Bahman
Shah, Binay K.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1747.1747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1747
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
    Samir Dalia
    Julio Chavez
    Bryan Little
    Celeste Bello
    Kate Fisher
    Ji-Hyun Lee
    Paul Chervenick
    Lubomir Sokol
    Eduardo Sotomayor
    Bijal Shah
    Annals of Hematology, 2014, 93 : 1305 - 1312
  • [12] Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
    Brink, Mirian
    Kahle, Xaver U.
    Vermaat, Joost S. P.
    Zijlstra, Josee M.
    Chamuleau, Martine
    Kersten, Marie Jose
    Durmaz, Mujde
    Plattel, Wouter J.
    Lugtenburg, Pieternella J.
    Stevens, Wendy
    Mous, Rogier
    de Vries, Elisabeth G. E.
    van der Poel, Marjolein W. M.
    Panday, Prashant V. Nannan
    Huls, Gerwin
    van Meerten, Tom
    Nijland, Marcel
    BLOOD ADVANCES, 2021, 5 (15) : 2958 - 2964
  • [13] Protein Kinase C Delta in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Potential Prognostic Marker in Germinal Center B-Cell Lymphoma
    Zhang, Qunling
    Gu, Juan
    Xue, Kai
    Mavis, Cory
    Hernandez-Ilizaliturri, Francisco J.
    Cao, Junning
    Hong, Xiaonan
    Guo, Ye
    BLOOD, 2017, 130
  • [14] Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras
    Vahamurto, Pauli
    Mannisto, Susanna
    Pollari, Marjukka
    Karjalainen-Lindsberg, Marja-Liisa
    Makitie, Antti A.
    Leppa, Sirpa
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 457 - 464
  • [15] Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era
    Beygi, Sara
    Sadashiv, Santhosh
    Reilly, James B.
    Khan, Cyrus
    Lister, John
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2847 - 2861
  • [16] The Adhesion Molecule ICAM-1 in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Relationship with Prognostic Importance and Rituximab Resistance
    Zhang, Qunling
    Gu, Juan J.
    Mavis, Cory
    Guo, Ye
    Barth, Matthew J.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2016, 128 (22)
  • [17] The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance
    Liu, Yizhen
    Gu, Juan J.
    Yang, Ling
    Tsai, Ping-Chiao
    Guo, Ye
    Xue, Kai
    Xia, Zuguang
    Liu, Xiaojian
    Lv, Fangfang
    Cao, Junning
    Hong, Xiaonan
    Mavis, Cory
    Hernandez-Ilizaliturri, Francisco J.
    Zhang, Qunling
    AGING-US, 2021, 13 (01): : 181 - 193
  • [18] Survival Trends Among Very Elderly Patients with Advanced Diffuse Large B-Cell Lymphoma - a Population Based Study
    Shah, Binay K.
    Ghimire, Krishna B.
    Pendharkar, Dinesh
    BLOOD, 2014, 124 (21)
  • [19] INTERIM POSITRON EMISSION TOMOGRAPHY SCAN PREDICTS EARLY OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE POST-RITUXIMAB ERA
    Yhim, H.
    Lee, N.
    Song, E.
    Jeon, S.
    Yim, C.
    Han, Y.
    Sohn, M.
    Lee, B.
    Kim, J.
    Park, Y. Ha
    Choi, W.
    Kim, H.
    Kwak, J.
    HAEMATOLOGICA, 2013, 98 : 134 - 135
  • [20] Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era
    Fletcher, Christopher D.
    Kahl, Brad S.
    LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2228 - 2240
12345